GlassScriptPhysician profile
Michael James Byrd
NPI 1497203640
$1,252.15
in general payments reported to CMS, 2019-2025
17 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.73 · 2022: $907 · 2023: $103 · 2024: $43.48 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.68 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $281.76 | 2022-2023 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $201.55 | 2022-2024 | Dupixent |
| Seagen INC. | $198.00 | 2022-2025 | |
| Janssen Biotech, INC. | $159.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $112.66 | 2022 | |
| Amgen INC. | $39.28 | 2021-2022 | |
| Inspire Medical Systems, INC. | $38.77 | 2025 | Inspire |
| Abbvie INC. | $33.07 | 2022 | |
| Genzyme Corporation | $24.92 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.23 | 2022 | |
| Incyte Corporation | $24.05 | 2022 | |
| Integra Lifesciences Corporation | $22.22 | 2021 | |
| Lilly USA, LLC | $21.16 | 2022 | |
| Eisai INC. | $20.33 | 2025 | |
| Merck Sharp & Dohme LLC | $18.90 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $16.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.